Multi-Path Optimization for Efficient Production of 2'-Fucosyllactose in an Engineered Escherichia coli C41 (DE3) Derivative
- PMID: 33425876
- PMCID: PMC7793955
- DOI: 10.3389/fbioe.2020.611900
Multi-Path Optimization for Efficient Production of 2'-Fucosyllactose in an Engineered Escherichia coli C41 (DE3) Derivative
Abstract
2'-fucosyllactose (2'-FL), one of the simplest but most abundant oligosaccharides in human milk, has been demonstrated to have many positive benefits for the healthy development of newborns. However, the high-cost production and limited availability restrict its widespread use in infant nutrition and further research on its potential functions. In this study, on the basis of previous achievements, we developed a powerful cell factory by using a lacZ-mutant Escherichia coli C41 (DE3)ΔZ to ulteriorly increase 2'-FL production by feeding inexpensive glycerol. Initially, we co-expressed the genes for GDP-L-fucose biosynthesis and heterologous α-1,2-fucosyltransferase in C41(DE3)ΔZ through different plasmid-based expression combinations, functionally constructing a preferred route for 2'-FL biosynthesis. To further boost the carbon flux from GDP-L-fucose toward 2'-FL synthesis, deletion of chromosomal genes (wcaJ, nudD, and nudK) involved in the degradation of the precursors GDP-L-fucose and GDP-mannose were performed. Notably, the co-introduction of two heterologous positive regulators, RcsA and RcsB, was confirmed to be more conducive to GDP-L-fucose formation and thus 2'-FL production. Further a genomic integration of an individual copy of α-1,2-fucosyltransferase gene, as well as the preliminary optimization of fermentation conditions enabled the resulting engineered strain to achieve a high titer and yield. By collectively taking into account the intracellular lactose utilization, GDP-L-fucose availability, and fucosylation activity for 2'-FL production, ultimately a highest titer of 2'-FL in our optimized conditions reached 6.86 g/L with a yield of 0.92 mol/mol from lactose in the batch fermentation. Moreover, the feasibility of mass production was demonstrated in a 50-L fed-batch fermentation system in which a maximum titer of 66.80 g/L 2'-FL was achieved with a yield of 0.89 mol 2'-FL/mol lactose and a productivity of approximately 0.95 g/L/h 2'-FL. As a proof of concept, our preliminary 2'-FL production demonstrated a superior production performance, which will provide a promising candidate process for further industrial production.
Keywords: 2′-fucosyllactose; Escherichia coli; GDP-D-mannose; GDP-L-fucose; fucosylation.
Copyright © 2020 Ni, Li, Wu, Ge, Liao, Yuan, Chen and Yao.
Conflict of interest statement
JW, LY, and XC were employed by the company Wuhan Zhongke Optics Valley Green Biotechnology Co. Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

















Similar articles
-
Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose.Microb Cell Fact. 2013 May 1;12:40. doi: 10.1186/1475-2859-12-40. Microb Cell Fact. 2013. PMID: 23635327 Free PMC article.
-
Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli.Microb Cell Fact. 2012 Apr 30;11:48. doi: 10.1186/1475-2859-11-48. Microb Cell Fact. 2012. PMID: 22545760 Free PMC article.
-
Enhanced production of 2'-fucosyllactose in engineered Escherichia coli BL21star(DE3) by modulation of lactose metabolism and fucosyltransferase.J Biotechnol. 2015 Sep 20;210:107-15. doi: 10.1016/j.jbiotec.2015.06.431. Epub 2015 Jul 17. J Biotechnol. 2015. PMID: 26193630
-
Strategies for Enhancing Microbial Production of 2'-Fucosyllactose, the Most Abundant Human Milk Oligosaccharide.J Agric Food Chem. 2022 Sep 21;70(37):11481-11499. doi: 10.1021/acs.jafc.2c04539. Epub 2022 Sep 12. J Agric Food Chem. 2022. PMID: 36094047 Review.
-
Biotechnological production of fucosylated human milk oligosaccharides: Prokaryotic fucosyltransferases and their use in biocatalytic cascades or whole cell conversion systems.J Biotechnol. 2016 Oct 10;235:61-83. doi: 10.1016/j.jbiotec.2016.03.052. Epub 2016 Apr 1. J Biotechnol. 2016. PMID: 27046065 Review.
Cited by
-
Biosynthesis and metabolic engineering of natural sweeteners.AMB Express. 2025 Mar 18;15(1):50. doi: 10.1186/s13568-025-01864-y. AMB Express. 2025. PMID: 40100508 Free PMC article. Review.
-
Multi-level metabolic engineering of Escherichia coli for high-titer biosynthesis of 2'-fucosyllactose and 3-fucosyllactose.Microb Biotechnol. 2022 Dec;15(12):2970-2981. doi: 10.1111/1751-7915.14152. Epub 2022 Sep 22. Microb Biotechnol. 2022. PMID: 36134689 Free PMC article.
-
Intensification of 2'-Fucosyllactose biosynthesis pathway by using a novel fucosyltransferase from Bacillus cereus.Front Bioeng Biotechnol. 2025 Apr 30;13:1569597. doi: 10.3389/fbioe.2025.1569597. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40370597 Free PMC article.
-
Efficient production of 2'-fucosyllactose from fructose through metabolically engineered recombinant Escherichia coli.Microb Cell Fact. 2024 Feb 1;23(1):38. doi: 10.1186/s12934-024-02312-5. Microb Cell Fact. 2024. PMID: 38303005 Free PMC article.
-
Synthesis as an Expanding Resource in Human Milk Science.J Am Chem Soc. 2021 Aug 4;143(30):11277-11290. doi: 10.1021/jacs.1c05599. Epub 2021 Jul 23. J Am Chem Soc. 2021. PMID: 34296874 Free PMC article. Review.
References
-
- Abbott Laboratories. (2020). Similac. Available online at: https://similac.com/toddler-formula/go-grow-toddler-immune-support?utm_c... (accessed July 15, 2020).
-
- Bhattacharya S. K., Dubey A. K. (1995). Metabolic burden as reflected by maintenance coefficient of recombinant Escherichia coli overexpressing target gene. Biotechnol. Lett. 17, 1155–1160. 10.1007/BF00128377 - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials